Annual Report and Accounts – Notice of Annual General Meeting: 26 May 2016

4th May 2016 - 2:08 pm

ImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2015 has been posted to shareholders.

The 2015 Annual Report can be downloaded here

The Company’s Annual General Meeting will be held on Thursday 26 May 2016 at 10:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

Share this article

Leave a comment